Sort
50,496 grants matching “lung cancer”
Joint receptor and protein expression immunophenotyping through split-pool barcoding
$396,213Georg Seelig · University Of Washington · R33 · FY2023 · CA
The role of Bik in the replication and severity of influenza A virus
$396,208Yohannes Afework Mebratu · Ohio State University · R01 · FY2025 · AI
The role of Bik in the replication and severity of influenza A virus
$396,208Yohannes Afework Mebratu · Ohio State University · R01 · FY2024 · AI
CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)
$396,181Rowan A Chlebowski · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · M01 · FY2008 · RR
A Regulatory Cascade that Controls Pneumococcal Capsule Biosynthesis
$396,177Andrew T Ulijasz · Loyola University Chicago · R01 · FY2022 · AI
Advanced Imaging Core
$396,177David Entenberg · Albert Einstein College Of Medicine · P01 · FY2024 · CA
A Regulatory Cascade that Controls Pneumococcal Capsule Biosynthesis
$396,176Andrew T Ulijasz · Loyola University Chicago · R01 · FY2023 · AI
Inherited genetic risk factors common to COPD and lung cancer.
$396,157James C Willey · University Of Toledo Health Sci Campus · R01 · FY2014 · HL
Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer
$396,130Ming Hui Chen · Duke University · R01 · FY2025 · CA
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
$396,116Binfeng Lu · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
RAS dysregulation during HDIL2: a clinical model of sepsis-induced lung injury
$396,103Kevin C Doerschug · University Of Iowa · R56 · FY2015 · HL
Training Grant in Lung Cell and Molecular Biology
$396,100Benjamin D Medoff · Massachusetts General Hospital · T32 · FY2009 · HL
IRS-1 Regulates Inflammatory Cell Recruitment in Lung Cancer
$396,096A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Cancer Care and Outcomes for Disabled Medicare Patients
$396,092Beth Israel Deaconess Medical Center · R01 · FY2005 · CA
MicroRNA Therapy for Lymph Node Metastatic Breast Cancer
$396,090Zdravka O. Medarova · Massachusetts General Hospital · R01 · FY2012 · CA
Prospective Studies of Diet and Cancer in Men and Women
$396,040Walter C. Willett · Harvard School Of Public Health · P01 · FY2009 · CA
Induction of cytotoxic T cells by pulmonary dendritic cells
$396,023Claudia V Jakubzick · National Jewish Health · R01 · FY2016 · HL
Semiparametric Regression Analysis of Interval-Censored Data in Current Cohort Studies
$396,020Donglin Zeng · University Of Michigan At Ann Arbor · R01 · FY2024 · HL
Understanding Resistance to Next Generation Antiandrogens
$396,018Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Induction of cytotoxic T cells by pulmonary dendritic cells
$396,016Claudia V Jakubzick · National Jewish Health · R01 · FY2017 · HL
Alpha 5 nAChR is a Risk Factor within the Dopamine System for Nicotine Addiction
$396,000John A. Dani · University Of Pennsylvania · R01 · FY2016 · DA
Ultrasensitive measure of human mutagenesis: Connecting the exposome to disease
$396,000Jason H Bielas · Fred Hutchinson Cancer Research Center · R01 · FY2019 · ES
Ultrasensitive measure of human mutagenesis: Connecting the exposome to disease
$396,000Jason H Bielas · Fred Hutchinson Cancer Research Center · R01 · FY2017 · ES
Ultrasensitive measure of human mutagenesis: Connecting the exposome to disease
$396,000Jason H Bielas · Fred Hutchinson Cancer Research Center · R01 · FY2016 · ES
Development of deazaflavin analogs as potent and selective MRP1 inhibitors for cancer chemosensitization
$395,973Jiashu Xie · University Of Minnesota · R21 · FY2025 · CA